EUVIMEDOpdag EUVIMED
Crossref

Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials

Marta Letizia Hribal, Giorgio Sesti

Clinical Investigation · 2011

DOI: 10.4155/cli.10.26 ↗

At a glance

Journal article in Clinical Investigation, 2011. Written by Marta Letizia Hribal and 1 co-authors. Cited 1 times so far (Crossref); 64 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Cite

APA

Hribal, M. L., & Sesti, G. (2011). Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials. Clinical Investigation. https://doi.org/10.4155/cli.10.26

Vancouver

Hribal ML, Sesti G. Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials. Clinical Investigation. 2011. doi:10.4155/cli.10.26

BibTeX
@article{Hribal2011,
  author = {Hribal, Marta Letizia and Sesti, Giorgio},
  title = {Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials},
  journal = {Clinical Investigation},
  year = {2011},
  doi = {10.4155/cli.10.26}
}
Start for free →